LERCAPRESS 10 mg/10 mg

Opinions on drugs - Posted on Nov 10 2009

Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals.

Insufficient	The actual benefit of LERCAPRESS 10 mg/10 mg is insufficient in view of the available clinical data: this data is insufficient to assess its value for the management of hypertensive patients.
Substantial

no clinical added value

Not applicable

Évaluation des médicaments

My account